Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 46.67 USD 1.08% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Enovis Corp?
Write Note

Enovis Corp
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enovis Corp
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Enovis Corp
NYSE:ENOV
Net Issuance of Debt
$217.2m
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Net Issuance of Debt
$3.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Net Issuance of Debt
$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Issuance of Debt
$2.4B
CAGR 3-Years
N/A
CAGR 5-Years
17%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Net Issuance of Debt
-$2.4B
CAGR 3-Years
-257%
CAGR 5-Years
12%
CAGR 10-Years
-18%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Enovis Corp
Glance View

Market Cap
2.6B USD
Industry
Health Care

Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.

ENOV Intrinsic Value
72.78 USD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Enovis Corp's Net Issuance of Debt?
Net Issuance of Debt
217.2m USD

Based on the financial report for Dec 31, 2023, Enovis Corp's Net Issuance of Debt amounts to 217.2m USD.

What is Enovis Corp's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
7%

Back to Top